Esophageal squamous cell carcinoma (ESCC) is a highly aggressive malignancy with poor prognosis, and understanding the molecular mechanisms underlying its progression is crucial for developing ...

Esophageal squamous cell carcinoma (ESCC) is a severe health threat, being a predominant subtype of esophageal cancer and contributing significantly to cancer-related mortality globally.

AN experience with 335 cases of carcinoma of ... found in the mid-esophagus. We have had 5 such cases. Lesions above the pyriform sinus are classified as transitional-cell carcinomas or ...

The safety and short-term efficacy of neoadjuvant chemotherapy in elderly patients with resectable locally advanced esophageal squamous cell carcinoma. This is an ASCO Meeting Abstract from the 2025 ...

Ashfaq Marghoob provides skin cancer care to the residents of Long Island at MSK’s dedicated skin cancer center in Hauppaugue. Most cases of squamous cell carcinoma can be cured when found early and ...

Early and late responders with esophageal squamous cell carcinoma experienced comparable OS benefits with Tevimbra plus chemo ...

Barrett's esophagus is an acquired metaplastic abnormality in which the normal stratified squamous epithelium lining ... Barrett's esophagus and its progression to cancer remain unclear.

A total of 68 superficial esophageal ... cancer (P < 0.0001). Fifteen of 46 HGINs or cancers had non-brownish epithelium because some HGIN and cancer cases showed the presence of abnormal cells ...

Comparison between neoadjuvant chemotherapy followed by surgery and definitive chemoradiotherapy for survival in patients with resectable esophageal squamous cell carcinoma (JCOG2305A). This is an ...

More information: Bo Tian et al, Dysregulated inclusion of BOLA3 exon 3 promoted by HNRNPC accelerates the progression of esophageal squamous cell carcinoma, Frontiers of Medicine (2024). DOI: 10. ...